Hasbro Was Not Toying Around With Q4 Earnings

Companies and Brands

Published: February 11, 2020 10:50 am

When Hasbro Inc. (NASDAQ: HAS) reported its fourth-quarter financial results before the markets opened on Monday, the toymaker said that it had $1.33 in earnings per share (EPS) and $1.43 billion in revenue. The consensus estimates had called for $0.91 in EPS and $1.44 billion in revenue, and the same period of last year reportedly had EPS of $1.33 on $1.39 billion in revenue.

Note that while Hasbro completed its acquisition of eOne in the first quarter, the impact was not reflected in the report.

Fourth-quarter revenue was bolstered by strong demand for Hasbro’s products for Disney’s “Frozen 2” and Star Wars.

In terms of its segments, the company reported as follows:

Franchise Brands net revenues shrank 9% year over year to $661.9 million.
Partner Brands net revenues increased by 50% to $408.5 million.
Hasbro Gaming net revenues decreased 8% to $246.5 million.
Emerging Brands net revenues fell 7% to $111.1 million.

The company did not offer any outlook in the report. However, consensus estimates are calling for $0.30 in EPS and $1.09 billion in revenue for the first quarter.

Brian Goldner, Hasbro’s board chair and chief executive, commented:

The global Hasbro team delivered a good year and achieved key objectives we set for 2019. We profitably grew revenues across regions absent foreign exchange supported by the successful execution of our channel strategy; we delivered growth in MAGIC: THE GATHERING driven by the successful launch of Arena and we executed at a high level during the holiday season. Our acquisition of Entertainment One accelerates our Brand Blueprint strategy and significantly expands our expertise and capabilities as a global play and entertainment company. Our teams are actively engaged to unlock value across our organization – in gaming, in toys, in consumer products and in entertainment.

After spiking nearly 8% just after the opening bell, Hasbro stock was last seen up about 1% at $101.98, with a consensus price target of $116.27 and a 52-week trading range of $82.87 to $126.87.

ALSO READ: 5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.